the Ethics Committee of Medical and Surgical Research Center, Ondokuz Mayıs University Faculty of Medicine. During the study period, all rats had access to water and food ad lib and were kept in cages exposed to alternate 12 hours of dark and light under 21±2°C room temperature. All rats were fasted overnight before the procedure. On the day of the experiment, the rats that were given ketamine (Ketalar, Pfizer, Istanbul, Turkey) anaesthesia (100 mg/kg) via the intraperitoneal (i.p.) route were fixed on a stereotactic surgical apparatus (Stoelting Inc., IL, USA). Then, as described by Paxinos and Watson (10) , a burr hole was opened 1.1 mm posterior and 1.5 mm lateral to the bregma, and a stainless steel catheter was inserted into the cranium and advanced deeply for 3.5 mm. After observing the outflow of cerebrospinal fluid from the catheter lumen, it was fixed and immobilised with dental acrylic resin and its external end was closed with a plastic plug. For prophylaxis, all rats were given 30 mg/kg ampicillin i.p.
Experimental design
The rats were randomly allocated into two groups 3 days after catheterisation. Rats in the dexmedetomidine group (Group D, n=16) received 3 µg (0.03 mL) dexmedetomidine (Precedex; Hospira, 100 μg/mL); the control group (Group C, n=16) received 0.03 mL physiological serum through an intracerebroventricular catheter once a day, for 5 days. Rats displaying abnormal posture, motor deficit, infection, and impaired health state were excluded from the study.
Nociceptive, motor function, and sedation assessment tests were applied for 5 days between 9 AM and 5 PM, before and 5, 10, 20, 30, 40, 60, and 90 min after injections in a random fashion every day. Pre-injection values were recorded as baseline, and post-injection values were recorded as test variables.
Nociceptive evaluation
Thermal stimulation models were used.
Hot plate test (supraspinal pain test):
The test was performed according to the method described by Eddy and Leimbach (11) . Reaction times of the rats placed on a hot metal plate apparatus with a thermostat that kept the temperature of the plate at 55±0.5°C (Ugo Basile, Thermal Plantar TM , Verase, Italy) were recorded. Jumping, licking, or withdrawing of the hind paws were accepted as a positive reaction. The time interval between placing the rat on the hot plate and the first sign of a positive reaction was also recorded. To prevent tissue damage, rats were left on the hot plate for 60 seconds at most.
Tail-flick test (spinal pain test):
The test was performed according to the method described by D'Amour and Smith (12) . The tail of the rat was half dipped in a water tank with a stable temperature of 55±0.5°C. Tail flick or an audible reaction was accepted as a positive reaction, and the time interval between immersion of the tail and the first sign of a positive reaction was recorded. To prevent tissue damage, the duration of the tail-flick test was limited to 15 seconds.
Latencies (reaction times) measured during hot plate and tail-flick tests were compared with baseline values to calculate the percentage of maximum possible effect (MPE): MPE (%) = 100 x [(test value -baseline value) / (cut-off time -baseline value)]
Sedation level: Based on the severity of reactions induced by vocal and tactile stimuli, the degree of sedation was evaluated between 0 and 2 (0=active, 1=tendency to sleep, response to stimuli; 2=sleepy, no response to stimuli) (13) .
Motor function: Stepping and righting reflexes were evaluated using the Yamamoto scoring system (14) . The responses obtained during these tests ranged between 0 and 2 (0=no motor response; 1=slower than normal motor response; 2=normal motor response).
Histopathological evaluation
Half of the rats in both groups (eight rats from each group) were sacrificed on the 6 th day and the remaining rats (eight rats from each group) were sacrificed on the 21 st day after intracerebroventricular injection, and then the perfusion fixation method was applied with 10% formaldehyde. For histopathological evaluation, laminectomies were performed to extract the medulla spinalis of the rats. The first tissue section was obtained from the cervical spinal cord 1 cm distal to the proximal end of the spinal cord. The second sample was retrieved from the region 1 cm distal from the thoracic 13-lumbar 1 vertebra, corresponding to the last rib of the rat. All tissue samples were embedded in paraffin blocks. From each paraffin block, four pieces of 8-µm thick sections were obtained, stained with haematoxylin-eosin, and evaluated under a light microscope by a pathologist blinded to the study design.
On morphological evaluation, nonspecific changes like edema and gliosis, signs of neuronal degeneration demonstrating a severe reaction, and density of inflammatory cells were examined. Using a scoring system described by Koizumi et al. (15) , each histomorphological parameter was scored numerically as 0, 1, and 2 points, and the degree of destructive changes was interpreted based on the total score. Total scores were recorded as nonspecific (0-3 points), mild (4-6 points), and markedly severe (7-10 points) changes.
Statistical analysis
Data were transferred into the SPSS 13.0 software package. Wilcoxon test was used for comparison of repeated measures during hot plate and tail-flick tests, and Mann-Whitney U test was used for intergroup comparison of MPE values. For qualitative data of histopathological evaluations, Fisher's exact test was applied. Data are expressed as median (minmax) and percentages. p<0.05 was considered statistically significant.
Results
Two rats were excluded from the study on the second day of experiments because of deterioration in general health state such as lassitude and rejection of being fed. In dexmedetomidine-administered rats, reaction times at 5, 10, and 20 min on the first day and reaction times at 5, 10, 20, and 30 min on the other days in hot plate tests were significantly longer compared with baseline values (p<0.05) ( Table 1 ). In addition, reaction times at 90 min on the first day, at 60 min on the second day, at 40, 60, and 90 min on the third day, and at 90 min on the fifth day in hot plate tests were significantly shorter compared with baseline values (p<0.05) ( Table 1) .
In dexmedetomidine-administered rats, reaction times at 5, 10, 20, 30, and 40 min on the first, fourth, and fifth days and reaction times at 5, 10, 20, and 30 min on the second and third days in tail-flick tests were significantly longer compared with baseline values (p<0.05) ( Table 2 ).
The percentage of MPE in hot plate and tail-flick tests were significantly longer at all times in dexmedetomidineadministered rats compared with the control group (p<0.05). First-degree sedation lasting for 60 min was observed in all rats in the dexmedetomidine group. Sedation was not observed in the control group. First-degree block lasting for 30-40 min in stepping and righting reflexes were observed in all rats in the dexmedetomidine group. No reflex loss was observed in any rat in the control group. Table 2 . Tail-flick test reaction times (in sec) for 5 days in dexmedetomidine-administered rats Similar rates of nonspecific changes such as edema and gliosis were seen in both groups. Signs of severe reactions such as neuronal degeneration and diffuse inflammatory cell infiltration were not encountered in any group (Figures 1-4) . According to histopathological findings of both regions of the spinal cord, no significant intergroup difference was detected on the 6 th or the 21 st day (p>0.05) ( Tables 3, 4 ).
Discussion
Compared with other alpha 2 agonists, dexmedetomidine has a higher receptor specificity, selectivity, and potentially increased analgesic efficacy. Therefore, it can be an ideal adjuvant to local anaesthetics in neuroaxial blocks. The analgesic effect of dexmedetomidine has been investigated in many (23) found that addition of 5 µg dexmedetomidine to 10 mg bupivacaine intrathecally in patients before major abdominal cancer surgery improved the duration and quality of postoperative analgesia. In a previous study, Xiang et al. (24) added dexmedetomidine to bupivacaine in 60 children aged 1-6 years. Thirty children received 1 mL/kg volume of 0.25% bupivacaine plus 1 μg/kg dexmedetomidine caudally. Other children received 1 mL/kg of 0.25% bupivacaine. They concluded that addition of dexmedetomidine to bupivacaine caudally reduced the response to hernial sac traction and improved the duration of postoperative analgesia. In our study, we used the lowest effective analgesic dose of dexmedetomidine, 3 µg (approximately 10 µg/kg), and similarly detected that this dose-induced significant increase in latent periods, as evaluated by the tail-flick and hot plate tests. The reaction times at 90 min on the first day, at 60 min on the second day, at 40, 60, and 90 min on the third day, and at 90 min on the fifth day in hot plate tests were shorter than baseline values. A shorter reaction time compared with baseline values depends on the learning phenomena of rats (25) .
Although dexmedetomidine is not effective on the neuromuscular junction, it exerts a central effect on muscles, like benzodiazepines. It can provide muscular relaxation via central pathways without affecting the neuromuscular junction (26) . Similarly, we observed the loss of stepping and righting reflexes in rats that received intrathecal dexmedetomidine. However, this effect might be related to decreased muscular tone secondary to sedation and the central effects of dexmedetomidine.
Dexmedetomidine exerts its anxiolytic and sedative effects via activation of alpha 2 adrenoceptors in the locus coeruleus, which is the major adrenergic innervation area in the central nervous system. Dexmedetomidine can provide sedoanalgesia especially without inducing respiratory depression. It is a potent selective alpha 2 agonist with sedative, analgesic, and anxiolytic properties (27) . Burkle et al. (28) administered three different alpha adrenergic agonists to rats, i.e., dexmedetomidine, clonidine, and UK-14.304 via the intracerebroventricular route, at doses of 3-10 μg, 10-100 μg, and 3-30 μg, and detected stronger sedative effects of dexmedetomidine compared with the other agonists. In our study, we also observed a prominent sedative effect with 3 µg dexmedetomidine, which developed very rapidly and immediately after intracerebroventricular administration of the drug.
Drugs directly administered through the intrathecal route carry risks of central nervous system damage and neurotoxicity. Safe usage of intrathecally administered drugs requires unequivocal disclosure of their effects on the central nervous system. In rats that received only physiological saline injections through an intrathecal catheter, numerous mononuclear inflammatory cells in the regions adjacent to the leptomeninx along the course of the catheter were seen, while inflammatory cell infiltration occurred less frequently in rats that were only catheterised (29) . Therefore, we preferred to use the intracerebroventricular catheterisation technique, which has no direct contact with the spinal cord in order to prevent the occurrence of potential histopathological adverse effects (fibrosis and lymphocytic infiltration) secondary to the implantation of an intrathecal catheter.
This study has several limitations. We administered dexmedetomidine intracerebroventricularly; furthermore, it was not shown that dexmedetomidine reached the spinal area, and no samples were obtained from the locus coeruleus for histopathological evaluation. Thus, although neurotoxicity was not observed in the spinal cord it does not mean that it was not present in other parts of the nervous system and ventricular system.
In previous studies, with intrathecal administration of higher doses of the alpha 2 agonist clonidine, no neurotoxic (34) found that intravenous administration of 15 µg/ kg dexmedetomidine protected the brain against focal cerebral ischaemia/reperfusion in rats after middle cerebral artery occlusion. They concluded that dexmedetomidine decreased the neurological deficit score, brain edema, cerebral infarct volume, and neuronal death. Brummet et al. (35) added dexmedetomidine to bupivacaine for sciatic nerve block in rats to evaluate its neurotoxic effect. In their study, they used higher doses (28-40 μg/kg) of dexmedetomidine. They performed histopathological evaluations at 24 hours, and 14 days later and demonstrated that all of the nerves had normal axons and myelin. In the present study, we also did not encounter any finding to suggest the neurotoxicity of dexmedetomidine.
In conclusion, intracerebroventricular administration of 3 µg dexmedetomidine in rats induces antinociceptive and sedative effects without any neurotoxic impact on the spinal cord.
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